Blood-Brain Barrier Finding May Offer Insights on Cognitive Decline of Aging

    National Institutes of Health investigators studying zebrafish have determined that a population of cells that protect the brain against diseases and harmful substances (blood–brain barrier) are not immune cells, as had previously been thought, but instead likely arise from the lining of the circulatory system.

    This finding may have implications for understanding age-related decline in brain functioning and how the human immunodeficiency virus (HIV) infects brain cells, according to the research team.

    The study (“A Novel Perivascular Cell Population in the Zebrafish Brain”), which appears online in eLife, was conducted by researchers at NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and National Human Genome Research Institute and the Japanese National Institute of Genetics.

    The scientists showed that fluorescent granular perithelial cells (FGPs), which act as sentries, engulfing toxins, cellular wastes, and microbes and then encasing them in vesicles, are present on the surface of the zebrafish brain and that these blood vessel-associated FGPs do not arise from the immune system, as had been previously thought, but from endothelial cells themselves.

    FGPs are thought to be important in a variety of human brain disorders and conditions. These cells appear to be a major entry point for HIV infection of the brain. Age-related decline in cognitive function is associated with a decline in the scavenging function of FGPs. “Learning more about how FGPs function may lead to a greater understanding of dementia and other conditions,” said the study’s senior author, Brant Weinstein, Ph.D., of NICHD’s Section on Vertebrate Organogenesis.

    The Weinstein lab studies zebrafish to understand how the blood and lymphatic systems develop. Because the young fish are transparent, it is possible to see the developing circulatory system while observing the fish under a light microscope. As part of this effort, Dr. Weinstein and his colleagues inserted a gene for a protein that turns green the cells that line the endothelium of selected embryonic veins and in the lymphatic system. In addition to seeing green lymphatic cells in the zebrafish embryos, the researchers noticed that green cells also covered the surface of the tiny fish’s brains.

    Upon closer inspection, the researchers tentatively identified these cells as FGPs. Because they turned green, it was apparent that they arose from endothelial cells. Until the current study, FGPs were thought to be macrophages, a type of immune cell. The researchers conducted additional experiments to confirm the origins of the FGPs, including analyzing what proteins were being made by their DNA. These proteins most closely resembled those made by endothelial cells in the lymphatic system, not the proteins made by macrophages or other immune cells. In another series of experiments, they inserted a green fluorescent protein into the tissues that give rise to blood and lymph vessels in embryonic zebrafish.

    Using time-lapse photography, the researchers captured images of FGPs arising from the vessels’ endothelium. When zebrafish with the green fluorescing endothelial gene matured, the researchers observed green FGPs on the surface of the fish’s brains—confirming that these cells arose from endothelial tissue.

    The researchers hope to conduct further studies of how FGPs interact with blood vessels and the blood–brain barrier. The researchers noted that, unlike mammals, embryonic zebrafish can be observed under a microscope as they develop, providing an easy means for studying the role of FGPs in protecting the brain.